Nabla Bio secures $26m in Series A funding round
Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportNabla Bio secures $26m in Series A funding round